Cue Health Raised US$200 Million at IPO and Plans to Expand Portable Diagnostic Testing

Cue Health Raised US$200 Million at IPO and Plans to Expand Portable Diagnostic Testing

Cue Health is paving the way for the digital transformation of healthcare.

Founded in San Diego in 2010, Cue Health is the latest med-tech startup to become a publicly listed company after a sharp term to profitability this year. Having found success in developing a portable COVID-19 test kit that provides lab-quality results in just a few minutes, it now hopes to expand its influence beyond the pandemic and into every corner of healthcare.

On September 23, 2021, Cue Health announced the pricing of its initial public offering (IPO) of 12,500,000 shares of its common stock at a public offering price of US$16 per share, for gross proceeds of US$200 million. 

This announcement came after a round of successes duly celebrated by the company. In October last year, Cue Health nabbed a whopping US$481 million from the United States Department of Defense under the Other Transaction Agreement to expand its production capacity of COVID test kits. In May this year, the company received another US$235 million from its investors, including Johnson & Johnson Innovation, ACME Capital and Koch Industries.

Portable COVID-test

The company is most known for their portable COVID-19 testing kit. It tests for signs of COVID using a nasal swab, which is then inserted into a single-use cartridge and analyzed by the battery-powered Cue Reader. The analyzer wirelessly transmits test results to a connected mobile phone within 20 minutes. Users can check and manage their test results on their electronic devices through real-time, actionable and connected data.

The system became the first molecular COVID diagnostic to receive emergency authorization from the United States Food and Drug Administration for at-home and over-the-counter use without physician supervision or a prescription. In October this year, it was selected by the National Basketball Association (NBA) as the league’s “Official Home and Point of Care Test” for the 2021-22 season.

Expansion of its portable health tests 

COVID testing is not the only thing that Cue Health does. It also administers other tests, including ones that involve women’s health and sexual health, as well as for both flu and respiratory syncytial virus. The latter tests will be brought to clinical testing by the end of this year.

On October 6, 2021, Cue Health announced its newest collaboration with Google Cloud to attend to the dire need within the U.S. to track and sequence respiratory viral variants. With the power of Google Cloud’s leading-edge artificial intelligence, machine learning, analytics and privacy and security tools, Cue Health is aiming to reach more communities and have a greater impact in the fight against the current pandemic and any future ones. 

Header image courtesy of Cue Health

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Are There More Layoffs Coming in 2024?

Even as we kick off the new year, the horrors of the year past are not behind us. In 2023, major tech companies undertook big layoffs—in January last year, Google reduced its headcount by 6% (it also recently hinted at a fresh round of layoffs this year); in December 2023, Spotify laid off 17% of its staff and more companies gave out pink slips. This trend has been ongoing for a couple of years since the pandemic shook global markets.

GuideGeek Expands to Facebook Messenger to Offer Personalized Travel Tips

GuideGeek, Matador Network’s AI travel assistant powered by OpenAI, is now accessible to Facebook Messenger users, expanding its reach beyond WhatsApp and Instagram. This move aims to place GuideGeek in the hands of more travelers globally, offering instant, personalized travel tips at no cost.

Elon Musk’s Neuralink Debuts Brain Chip Implant: A Bold Future with Ethical Questions

Elon Musk’s Neuralink is back in the spotlight with a major update: they’ve put a brain chip, called the Link, into a human for the first time. This small device has set its sights on monumental goals, such as helping people who’ve lost their limb functionality. Musk’s big dream doesn’t stop there—he wants the chip to boost our brains, improve our memory and eventually blend the human mind with artificial intelligence (AI).

Mercedes-Benz Launches the New Luxurious CLE Cabriolet

Mercedes-Benz has launched the CLE Cabriolet, building on its heritage of creating four-seater convertible vehicles. This new addition is characterized by its expressive design, advanced technology, and high-quality features, ensuring an enhanced driving experience. The model, which evolves from the CLE Coupé, stands out with its traditional fabric acoustic soft top and distinct high-quality details, making it uniquely positioned in the market. Designed to offer dynamic performance alongside exceptional daily comfort, the CLE Cabriolet supports year-round open-air enjoyment.

4 Companies Reusing Coffee Husk for Eco-Friendly Innovations

A daily cup of coffee is more than just a morning ritual—it’s a powerhouse of energy and health benefits. Beyond keeping you alert, coffee supports brain health, maintains liver function and may even lower the risk of depression. However, the journey of coffee from plantation to mug involves an energy-intensive process that produces significant waste, particularly coffee husks.